Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteosarcoma × merphos × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Burkitt Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Leukemia, Myeloid, Acute 2 Urinary Bladder Neoplasms 1 Rhabdoid Tumor 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Chronic 1 Hydatidiform Mole 1 Graft vs Host Disease 1 Down Syndrome 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Methotrexate 4 Doxorubicin 3 Ifosfamide 2 Etoposide 2 Cisplatin 2 peginterferon alfa-2b 1 merphos 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Specimen Handling 1 Platinum 1 IMVP-16 protocol 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Cyproheptadine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡